Condition: Acute Kidney Injury · Sponsor: BayCare Health System
To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
This description comes directly from the study's public registry record.
Tracy Johns, PharmD · 727-519-1310 · tracy.johns@baycare.org
Always discuss trial participation with your own doctor first.
| Morton Plant Hospital | Clearwater, Florida, United States | Recruiting |
| Morton Plant North Bay Hospital | New Port Richey, Florida, United States | Recruiting |
| Mease Countryside Hospital | Safety Harbor, Florida, United States | Recruiting |
| St. Anthony's Hospital | St. Petersburg, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07197957